ACS

Featured Article

The Uncertain Association Between Abacavir and the Risk for Acute Myocardial Infarction

The Uncertain Association Between Abacavir and the Risk for Acute Myocardial Infarction

A higher prevalence of traditional cardiovascular risk factors may be partially responsible for the increased incidence of cardiovascular disease in people living with HIV.

Latest Features

The Uncertain Association Between Abacavir and the Risk for Acute Myocardial Infarction

The Uncertain Association Between Abacavir and the Risk for Acute Myocardial Infarction

A higher prevalence of traditional cardiovascular risk factors may be partially responsible for the increased incidence of cardiovascular disease in people living with HIV.

Benefits of Inpatient Smoking Cessation Therapy Post-Myocardial Infarction

Benefits of Inpatient Smoking Cessation Therapy Post-Myocardial Infarction

Hospitals may be missing opportunities to start tobacco use treatment immediately after myocardial infarction.

Cardiac Rehabilitation: Changes, Challenges, and Clinician Perspectives

Cardiac Rehabilitation: Changes, Challenges, and Clinician Perspectives

An overview of cardiac rehabilitation use plus interviews with Monica Mukherjee, MD, MPH, FACC, FASE and with Jonathan Ledyard, MS, RCEP.

Assessing Chest Pain in ER With Short-term Risk Stratification Tool

Assessing Chest Pain in ER With Short-term Risk Stratification Tool

The HEART Score is a safe risk-stratification tool for chest pain, but it does not seem to do much for reducing hospital utilization and admissions.

Oxygen Therapy for Acute MI: Best Practice or Harmful Treatment?

Oxygen Therapy for Acute MI: Best Practice or Harmful Treatment?

Evidence is lacking to support oxygen therapy for acute myocardial infarction.

PCSK9 Inhibitor Alirocumab Associated With 75% Reduction in Apheresis

PCSK9 Inhibitor Alirocumab Associated With 75% Reduction in Apheresis

Among patients with heterozygous familial hypercholesterolemia, alirocumab was associated with a 75% reduction in lipoprotein apheresis compared with placebo.

Bioresorbable Stents Promising But Metal Stents Still Have Role in Coronary Intervention

Bioresorbable Stents Promising But Metal Stents Still Have Role in Coronary Intervention

Experts say bioresorbable stents are "a few generations away" from being standard of care in interventional cardiology.

Deferred Stenting or Ischemic Postconditioning in STEMI Patients Did Not Reduce Adverse Events

Deferred Stenting or Ischemic Postconditioning in STEMI Patients Did Not Reduce Adverse Events

A composite end point of death, heart failure, new myocardial infarction, and revascularization was similar between the deferred stenting group and the conventional treatment group.

Room for Improvement: Pharmacologic Management of Acute Coronary Syndromes

Room for Improvement: Pharmacologic Management of Acute Coronary Syndromes

Poor adherence to dual antiplatelet therapy plays a significant role in outcomes for patients with acute coronary syndromes.

Risk of Cardiovascular Disease Questioned in Testosterone Therapy Use

Risk of Cardiovascular Disease Questioned in Testosterone Therapy Use

The American Association of Clinical Endocrinologists site lack of evidence of cardiovascular disease risk in testosterone therapy use.

Latest News

Very Low High-Sensitivity Cardiac Troponin Levels May Exclude Inducible Myocardial Ischemia

Very Low High-Sensitivity Cardiac Troponin Levels May Exclude Inducible Myocardial Ischemia

Low hs-cTnI levels may identify patients with CAD who have a low medium-term risk for adverse cardiovascular events.

Pitavastatin Plus Ezetimibe May Improve Outcomes for ACS Without Hypertension

Pitavastatin Plus Ezetimibe May Improve Outcomes for ACS Without Hypertension

Combined treatment with pitavastatin and ezetimibe may be beneficial in patients with acute coronary syndrome and without hypertension for secondary prevention.

Influenza Infection Increases Mortality Risk in Acute Myocardial Infarction

Influenza Infection Increases Mortality Risk in Acute Myocardial Infarction

Investigators examined whether influenza is an independent risk factor for the development of acute myocardial infarction.

Strong Association Found Between Antiphospholipid Antibodies and First-Time MI

Strong Association Found Between Antiphospholipid Antibodies and First-Time MI

A strong association between antiphospholipid positivity and first-time MI may represent a risk factor for myocardial infarction.

Canagliflozin Approved to Reduce MACE Risk in Adults With Type 2 Diabetes and CVD

Canagliflozin Approved to Reduce MACE Risk in Adults With Type 2 Diabetes and CVD

The FDA has approved Invokana (canagliflozin) to reduce the risk of major CV events.

Point-of-Care Troponin Assay Facilitates Rapid Risk Stratification in Acute MI

Point-of-Care Troponin Assay Facilitates Rapid Risk Stratification in Acute MI

A novel point-of-care assay was shown to provide results within 15 minutes, thereby facilitating rapid risk stratification of patients with suspected acute MI.

Coronary CTA Reliably Assesses Long-Term Cardiovascular Risk

Coronary CTA Reliably Assesses Long-Term Cardiovascular Risk

Coronary computed tomography angiography is a reliable tool to assess long-term cardiovascular risk in suspected CCS.

Complete Revascularization Superior to Culprit-Only Intervention in NSTEMI

Complete Revascularization Superior to Culprit-Only Intervention in NSTEMI

Single-stage complete coronary revascularization appears to be superior to culprit-only lesion intervention in multivessel disease ACS.

Variable Period of Risk for Myocardial Infarction and Stroke Following Sepsis

Variable Period of Risk for Myocardial Infarction and Stroke Following Sepsis

Patients recovering from sepsis had an elevated risk for myocardial infarction or stroke in the first 4 weeks after hospital discharge compared to the general population.

Outcomes of Undetected Myocardial Infarction Examined

Outcomes of Undetected Myocardial Infarction Examined

Unrecognized MI detected by cardiac magnetic resonance imaging has similar mortality rates over the long term compared with recognized MI.